PlainRecalls
FDA Drug Moderate Class II Terminated

Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets per carton. Rx only, Manufactured by Laboratorios Leon Farma S.A. Spain for Sandoz Inc. Princeton, NJ 08540, NDC 0781-4058-15

Reported: July 24, 2013 Initiated: June 21, 2013 #D-805-2013

Product Description

Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets per carton. Rx only, Manufactured by Laboratorios Leon Farma S.A. Spain for Sandoz Inc. Princeton, NJ 08540, NDC 0781-4058-15

Reason for Recall

Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.

Details

Recalling Firm
Sandoz Incorporated
Units Affected
10,848 cartons
Distribution
Distributed to one consignee in Indiana. No foreign, government, VA, or military consignees.
Location
Broomfield, CO

Frequently Asked Questions

What product was recalled?
Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets per carton. Rx only, Manufactured by Laboratorios Leon Farma S.A. Spain for Sandoz Inc. Princeton, NJ 08540, NDC 0781-4058-15. Recalled by Sandoz Incorporated. Units affected: 10,848 cartons.
Why was this product recalled?
Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 24, 2013. Severity: Moderate. Recall number: D-805-2013.